Are we ignoring the most important coagulation factor when transfusing bleeding patients? Melissa Cushing thinks fibrinogen's contribution to survival of bleeding patients may be under-recognized. She describes the current evidence for early fibrinogen replacement in the bleeding patient, logistical challenges transfusion services face, studies providing insights to desired fibrinogen target levels, and future options to provide early fibrinogen replacement with increased efficiency and safety.

NOTE: CE credit has expired for this episode.